These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6597069)

  • 1. Role of the renal medulla in experimental hypertension.
    Russell GI; Taverner D; Jackson J; Bing RF; Swales JD; Thurston H
    Contrib Nephrol; 1984; 41():163-6. PubMed ID: 6597069
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension produced by chemical renal medullectomy: evidence for a renomedullary vasodepressor function in the rat.
    Taverner D; Bing RF; Fletcher A; Russell G; Swales JD; Thurston H
    Clin Sci (Lond); 1984 Nov; 67(5):521-8. PubMed ID: 6383693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of renal prostaglandins and dietary linoleate on hypertension in Dahl S rats.
    Tobian L; Ganguli M; Johnson MA; Iwai J
    Hypertension; 1982; 4(3 Pt 2):149-53. PubMed ID: 6950924
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical renal medullectomy and experimental hypertension.
    Russell GI; Bing RF; Taverner D; Swales JD; Thurston H
    Proc Eur Dial Transplant Assoc; 1983; 20():546-50. PubMed ID: 6581483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodepressor mechanisms in experimental hypertension: studies using chemical medullectomy.
    Swales JD; Bing RF; Russell GI; Taverner D; Thurston H
    J Hypertens Suppl; 1986 Oct; 4(4):S43-6. PubMed ID: 3534184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal vasodepressor mechanism: characterization by chemical medullectomy.
    Swales JD; Bing RF; Edmunds ME; Russell GI
    Am J Med Sci; 1988 Apr; 295(4):241-5. PubMed ID: 3284347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical renal medullectomy. Effect on urinary prostaglandin E2 and plasma renin in response to variations in sodium intake and in relation to blood pressure.
    Bing RF; Russell GI; Thurston H; Swales JD; Godfrey N; Lazarus Y; Jackson J
    Hypertension; 1983; 5(6):951-7. PubMed ID: 6360871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins and sodium balance during the reversal of chronic two-kidney, one clip hypertension in rats.
    Omata K; Abe K; Chiba S; Yasujima M; Sato M; Kudo K; Hagino T; Yoshinaga K; Otsuka Y
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):163-73. PubMed ID: 3469680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of renovascular hypertension: role of the renal medulla.
    Swales JD; Bing RF; Edmunds ME; Russell GI; Thurston H
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1566-71. PubMed ID: 3319107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of concentrating defect in hypercalcemia. Role of polydipsia and prostaglandins.
    Levi M; Peterson L; Berl T
    Kidney Int; 1983 Mar; 23(3):489-97. PubMed ID: 6573545
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrarenal prostaglandins E2 and F2 alpha in experimental renovascular hypertension.
    Soejima H; Nomura Y; Tsuruta K; Ikegami K
    Urol Int; 1981; 36(3):158-65. PubMed ID: 7281373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical renal medullectomy; effect upon reversal of two-kidney, one-clip hypertension in the rat.
    Bing RF; Russell GI; Swales JD; Thurston H; Fletcher A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():335s-338s. PubMed ID: 7318335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodepressor phospholipids in reversal of renal hypertension.
    Vandongen R
    Agents Actions Suppl; 1987; 22():85-91. PubMed ID: 3124557
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of prostaglandin E2 and indomethacin on the renal corticomedullary solute gradient in the rat.
    Haylor J; Lote CJ
    J Pharm Pharmacol; 1983 May; 35(5):299-305. PubMed ID: 6134798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the renal medulla in blood pressure control.
    Susić D
    Am J Med Sci; 1988 Apr; 295(4):234-40. PubMed ID: 3284346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prostaglandin synthesis inhibitors on the renin-angiotensin system and renal function.
    Izumi Y; Franco-Saenz R; Mulrow PJ
    Hypertension; 1985; 7(5):791-6. PubMed ID: 3861577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of gonad and renal prostaglandin E2 on the development of hypertension in spontaneously hypertensive rats.
    Matsudaira T; Kogo H; Satoh T
    Jpn J Pharmacol; 1985 Jan; 37(1):51-7. PubMed ID: 3857368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic reaction of normotensive and hypertensive rats to the administration of prostaglandins and indomethacin].
    Ismailov ShI; Val'dman AV
    Biull Eksp Biol Med; 1982 Aug; 94(8):45-8. PubMed ID: 6751430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.